GreenCentre Canada tops up seed funding of Mirexus Biotechnologies
Mirexus Biotechnologies Inc has secured a top-up investment to the seed-stage funding led by GreenSky Capital, a Toronto-based corporate finance advisory firm. The Guelph, Ontario-based Mirexus, which is commercializing sustainable nanoparticles useful in formulating greener, longer lasting personal care products and other applications, received an additional $150,000 from commercialization hub GreenCentre Canada. In March, the company was backed by members of GreenSky President’s Club (GPC) and other angel investors. GreenSky Capital sources, evaluates and manages opportunities for GPC.
17 June 2014•3 mins read
